Literature DB >> 24930574

Emerging roles of Notch signaling in liver disease.

Fabian Geisler1, Mario Strazzabosco.   

Abstract

This review critically discusses the most recent advances in the role of Notch signaling in liver development, homeostasis, and disease. It is now clear that the significance of Notch in determining mammalian cell fates and functions extends beyond development, and Notch is a major regular of organ homeostasis. Moreover, Notch signaling is reactivated upon injury and regulates the complex interactions between the distinct liver cell types involved in the repair process. Notch is also involved in the regulation of liver metabolism, inflammation, and cancer. The net effects of Notch signaling are highly variable and finely regulated at multiple levels, but also depend on the specific cellular context in which Notch is activated. Persistent activation of Notch signaling is associated with liver malignancies, such as hepatocellular carcinoma with stem cell features and intrahepatic cholangiocarcinoma. The complexity of the pathway provides several possible targets for agents able to inhibit Notch. However, further cell- and context-specific in-depth understanding of Notch signaling in liver homeostasis and disease will be essential to translate these concepts into clinical practice and be able to predict benefits and risks of evolving therapies.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24930574      PMCID: PMC4268103          DOI: 10.1002/hep.27268

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  61 in total

1.  A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

Authors:  Ju-Seog Lee; Jeonghoon Heo; Louis Libbrecht; In-Sun Chu; Pal Kaposi-Novak; Diego F Calvisi; Arsen Mikaelyan; Lewis R Roberts; Anthony J Demetris; Zongtang Sun; Frederik Nevens; Tania Roskams; Snorri S Thorgeirsson
Journal:  Nat Med       Date:  2006-03-12       Impact factor: 53.440

Review 2.  The canonical Notch signaling pathway: unfolding the activation mechanism.

Authors:  Raphael Kopan; Maria Xenia G Ilagan
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

3.  Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury.

Authors:  George K Michalopoulos; Lindsay Barua; William C Bowen
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

4.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

5.  Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice.

Authors:  Fabian Geisler; Florian Nagl; Pawel K Mazur; Marcel Lee; Ursula Zimber-Strobl; Lothar J Strobl; Freddy Radtke; Roland M Schmid; Jens T Siveke
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

6.  Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9.

Authors:  Aline Antoniou; Peggy Raynaud; Sabine Cordi; Yiwei Zong; François Tronche; Ben Z Stanger; Patrick Jacquemin; Christophe E Pierreux; Frederic Clotman; Frederic P Lemaigre
Journal:  Gastroenterology       Date:  2009-02-21       Impact factor: 22.682

7.  Bile duct proliferation in liver-specific Jag1 conditional knockout mice: effects of gene dosage.

Authors:  Kathleen M Loomes; Pierre Russo; Matthew Ryan; Anthony Nelson; Lara Underkoffler; Curtis Glover; Hong Fu; Thomas Gridley; Klaus H Kaestner; Rebecca J Oakey
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

8.  Disruption of the transcription factor recombination signal-binding protein-Jkappa (RBP-J) leads to veno-occlusive disease and interfered liver regeneration in mice.

Authors:  Lin Wang; Chun-Mei Wang; Li-Hong Hou; Guo-Rui Dou; Yao-Chun Wang; Xing-Bin Hu; Fei He; Fan Feng; Hong-Wei Zhang; Ying-Min Liang; Ke-Feng Dou; Hua Han
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

9.  Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.

Authors:  Luca Fabris; Massimiliano Cadamuro; Maria Guido; Carlo Spirli; Romina Fiorotto; Michele Colledan; Giuliano Torre; Daniele Alberti; Aurelio Sonzogni; Lajos Okolicsanyi; Mario Strazzabosco
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

10.  Notch signaling regulates bile duct morphogenesis in mice.

Authors:  Julie Lozier; Brent McCright; Thomas Gridley
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more
  102 in total

1.  Combination of sorafenib and Valproic acid synergistically induces cell apoptosis and inhibits hepatocellular carcinoma growth via down-regulating Notch3 and pAkt.

Authors:  Wanhu Zhu; Qing Liang; Xu Yang; Yan Yu; Xiaoying Shen; Guangchun Sun
Journal:  Am J Cancer Res       Date:  2017-12-01       Impact factor: 6.166

Review 2.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

3.  Inhibition of miR-21 rescues liver regeneration after partial hepatectomy in ethanol-fed rats.

Authors:  Egle Juskeviciute; Rachael P Dippold; Anil N Antony; Aditi Swarup; Rajanikanth Vadigepalli; Jan B Hoek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-15       Impact factor: 4.052

Review 4.  Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.

Authors:  Luca Fabris; Romina Fiorotto; Carlo Spirli; Massimiliano Cadamuro; Valeria Mariotti; Maria J Perugorria; Jesus M Banales; Mario Strazzabosco
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08       Impact factor: 46.802

Review 5.  Understanding the marvels behind liver regeneration.

Authors:  Anan Abu Rmilah; Wei Zhou; Erek Nelson; Li Lin; Bruce Amiot; Scott L Nyberg
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-03-28       Impact factor: 5.814

Review 6.  Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications.

Authors:  Eduardo Cervantes-Alvarez; Yang Wang; Alexandra Collin de l'Hortet; Jorge Guzman-Lepe; Jiye Zhu; Kazuki Takeishi
Journal:  Organogenesis       Date:  2017-01-05       Impact factor: 2.500

7.  Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.

Authors:  Wantae Kim; Sanjoy Kumar Khan; Jelena Gvozdenovic-Jeremic; Youngeun Kim; Jason Dahlman; Hanjun Kim; Ogyi Park; Tohru Ishitani; Eek-Hoon Jho; Bin Gao; Yingzi Yang
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

Review 8.  Emerging concepts in biliary repair and fibrosis.

Authors:  Luca Fabris; Carlo Spirli; Massimiliano Cadamuro; Romina Fiorotto; Mario Strazzabosco
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

Review 9.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

10.  Lineage fate of ductular reactions in liver injury and carcinogenesis.

Authors:  Simone Jörs; Petia Jeliazkova; Marc Ringelhan; Julian Thalhammer; Stephanie Dürl; Jorge Ferrer; Maike Sander; Mathias Heikenwalder; Roland M Schmid; Jens T Siveke; Fabian Geisler
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.